nodes	percent_of_prediction	percent_of_DWPC	metapath
Midazolam—Instillation site pain—Furosemide—dilated cardiomyopathy	0.0327	0.0493	CcSEcCtD
Midazolam—Hypotensive—Furosemide—dilated cardiomyopathy	0.0292	0.0441	CcSEcCtD
Midazolam—Application site pain—Furosemide—dilated cardiomyopathy	0.0242	0.0365	CcSEcCtD
Midazolam—Local reaction—Furosemide—dilated cardiomyopathy	0.0192	0.029	CcSEcCtD
Midazolam—Thrombosis—Furosemide—dilated cardiomyopathy	0.0151	0.0227	CcSEcCtD
Midazolam—ABCB1—Lisinopril—dilated cardiomyopathy	0.015	0.532	CbGbCtD
Midazolam—Lethargy—Spironolactone—dilated cardiomyopathy	0.0145	0.0219	CcSEcCtD
Midazolam—Sleep disturbance—Lisinopril—dilated cardiomyopathy	0.0143	0.0215	CcSEcCtD
Midazolam—Ataxia—Spironolactone—dilated cardiomyopathy	0.0134	0.0202	CcSEcCtD
Midazolam—ABCB1—Spironolactone—dilated cardiomyopathy	0.0132	0.468	CbGbCtD
Midazolam—Injection site pain—Furosemide—dilated cardiomyopathy	0.0131	0.0197	CcSEcCtD
Midazolam—Drowsiness—Spironolactone—dilated cardiomyopathy	0.011	0.0165	CcSEcCtD
Midazolam—Rhinorrhoea—Lisinopril—dilated cardiomyopathy	0.00987	0.0149	CcSEcCtD
Midazolam—Lightheadedness—Furosemide—dilated cardiomyopathy	0.00953	0.0144	CcSEcCtD
Midazolam—Thrombophlebitis—Furosemide—dilated cardiomyopathy	0.00893	0.0135	CcSEcCtD
Midazolam—Ventricular extrasystoles—Lisinopril—dilated cardiomyopathy	0.00885	0.0134	CcSEcCtD
Midazolam—Swelling—Furosemide—dilated cardiomyopathy	0.00877	0.0132	CcSEcCtD
Midazolam—Ventricular tachycardia—Lisinopril—dilated cardiomyopathy	0.00799	0.0121	CcSEcCtD
Midazolam—Anaphylactoid reaction—Furosemide—dilated cardiomyopathy	0.00799	0.0121	CcSEcCtD
Midazolam—Lethargy—Furosemide—dilated cardiomyopathy	0.00789	0.0119	CcSEcCtD
Midazolam—Wheezing—Lisinopril—dilated cardiomyopathy	0.00776	0.0117	CcSEcCtD
Midazolam—Salivary hypersecretion—Lisinopril—dilated cardiomyopathy	0.00776	0.0117	CcSEcCtD
Midazolam—Irritability—Furosemide—dilated cardiomyopathy	0.00738	0.0111	CcSEcCtD
Midazolam—Lightheadedness—Lisinopril—dilated cardiomyopathy	0.00715	0.0108	CcSEcCtD
Midazolam—Confusional state—Spironolactone—dilated cardiomyopathy	0.00705	0.0106	CcSEcCtD
Midazolam—Anaphylactic shock—Spironolactone—dilated cardiomyopathy	0.00699	0.0105	CcSEcCtD
Midazolam—Muscular weakness—Furosemide—dilated cardiomyopathy	0.00682	0.0103	CcSEcCtD
Midazolam—Sleep disorder—Lisinopril—dilated cardiomyopathy	0.0067	0.0101	CcSEcCtD
Midazolam—Injury—Lisinopril—dilated cardiomyopathy	0.00631	0.00953	CcSEcCtD
Midazolam—Somnolence—Spironolactone—dilated cardiomyopathy	0.00621	0.00937	CcSEcCtD
Midazolam—Gastrointestinal disorder—Spironolactone—dilated cardiomyopathy	0.00603	0.0091	CcSEcCtD
Midazolam—Anaphylactoid reaction—Lisinopril—dilated cardiomyopathy	0.006	0.00905	CcSEcCtD
Midazolam—Drowsiness—Furosemide—dilated cardiomyopathy	0.00596	0.00899	CcSEcCtD
Midazolam—Diplopia—Lisinopril—dilated cardiomyopathy	0.0058	0.00876	CcSEcCtD
Midazolam—Osteoarthritis—Lisinopril—dilated cardiomyopathy	0.0058	0.00876	CcSEcCtD
Midazolam—Feeling abnormal—Spironolactone—dilated cardiomyopathy	0.00576	0.00869	CcSEcCtD
Midazolam—Urticaria—Spironolactone—dilated cardiomyopathy	0.00555	0.00837	CcSEcCtD
Midazolam—Irritability—Lisinopril—dilated cardiomyopathy	0.00554	0.00836	CcSEcCtD
Midazolam—Cardiac arrest—Lisinopril—dilated cardiomyopathy	0.00552	0.00833	CcSEcCtD
Midazolam—Ataxia—Lisinopril—dilated cardiomyopathy	0.00546	0.00823	CcSEcCtD
Midazolam—Nasopharyngitis—Lisinopril—dilated cardiomyopathy	0.00519	0.00783	CcSEcCtD
Midazolam—Visual impairment—Furosemide—dilated cardiomyopathy	0.00516	0.00778	CcSEcCtD
Midazolam—Hypersensitivity—Spironolactone—dilated cardiomyopathy	0.00515	0.00777	CcSEcCtD
Midazolam—Eye disorder—Furosemide—dilated cardiomyopathy	0.005	0.00754	CcSEcCtD
Midazolam—Pruritus—Spironolactone—dilated cardiomyopathy	0.00494	0.00746	CcSEcCtD
Midazolam—Bronchospasm—Lisinopril—dilated cardiomyopathy	0.00493	0.00744	CcSEcCtD
Midazolam—Immune system disorder—Furosemide—dilated cardiomyopathy	0.00483	0.00729	CcSEcCtD
Midazolam—Erythema—Furosemide—dilated cardiomyopathy	0.00466	0.00703	CcSEcCtD
Midazolam—Dizziness—Spironolactone—dilated cardiomyopathy	0.00462	0.00697	CcSEcCtD
Midazolam—Depression—Lisinopril—dilated cardiomyopathy	0.00446	0.00673	CcSEcCtD
Midazolam—Vomiting—Spironolactone—dilated cardiomyopathy	0.00444	0.0067	CcSEcCtD
Midazolam—Rash—Spironolactone—dilated cardiomyopathy	0.00441	0.00665	CcSEcCtD
Midazolam—Dermatitis—Spironolactone—dilated cardiomyopathy	0.0044	0.00664	CcSEcCtD
Midazolam—Vision blurred—Furosemide—dilated cardiomyopathy	0.00439	0.00662	CcSEcCtD
Midazolam—Neuropathy peripheral—Lisinopril—dilated cardiomyopathy	0.00438	0.00661	CcSEcCtD
Midazolam—Headache—Spironolactone—dilated cardiomyopathy	0.00438	0.0066	CcSEcCtD
Midazolam—Agitation—Furosemide—dilated cardiomyopathy	0.00428	0.00646	CcSEcCtD
Midazolam—Vertigo—Furosemide—dilated cardiomyopathy	0.00418	0.00631	CcSEcCtD
Midazolam—Nausea—Spironolactone—dilated cardiomyopathy	0.00415	0.00626	CcSEcCtD
Midazolam—Bradycardia—Lisinopril—dilated cardiomyopathy	0.00409	0.00617	CcSEcCtD
Midazolam—Hallucination—Lisinopril—dilated cardiomyopathy	0.00399	0.00603	CcSEcCtD
Midazolam—Unspecified disorder of skin and subcutaneous tissue—Furosemide—dilated cardiomyopathy	0.00394	0.00594	CcSEcCtD
Midazolam—Dry mouth—Furosemide—dilated cardiomyopathy	0.00388	0.00585	CcSEcCtD
Midazolam—Confusional state—Furosemide—dilated cardiomyopathy	0.00383	0.00578	CcSEcCtD
Midazolam—Anaphylactic shock—Furosemide—dilated cardiomyopathy	0.0038	0.00574	CcSEcCtD
Midazolam—Shock—Furosemide—dilated cardiomyopathy	0.00374	0.00564	CcSEcCtD
Midazolam—Nervous system disorder—Furosemide—dilated cardiomyopathy	0.00373	0.00562	CcSEcCtD
Midazolam—Skin disorder—Furosemide—dilated cardiomyopathy	0.00369	0.00557	CcSEcCtD
Midazolam—Mediastinal disorder—Lisinopril—dilated cardiomyopathy	0.00362	0.00546	CcSEcCtD
Midazolam—Chills—Lisinopril—dilated cardiomyopathy	0.0036	0.00543	CcSEcCtD
Midazolam—Hypotension—Furosemide—dilated cardiomyopathy	0.00355	0.00536	CcSEcCtD
Midazolam—Mental disorder—Lisinopril—dilated cardiomyopathy	0.00352	0.00531	CcSEcCtD
Midazolam—Erythema—Lisinopril—dilated cardiomyopathy	0.00349	0.00527	CcSEcCtD
Midazolam—Tension—Lisinopril—dilated cardiomyopathy	0.00343	0.00517	CcSEcCtD
Midazolam—Paraesthesia—Furosemide—dilated cardiomyopathy	0.00341	0.00515	CcSEcCtD
Midazolam—Nervousness—Lisinopril—dilated cardiomyopathy	0.00339	0.00512	CcSEcCtD
Midazolam—Somnolence—Furosemide—dilated cardiomyopathy	0.00338	0.0051	CcSEcCtD
Midazolam—Vision blurred—Lisinopril—dilated cardiomyopathy	0.00329	0.00497	CcSEcCtD
Midazolam—Gastrointestinal disorder—Furosemide—dilated cardiomyopathy	0.00328	0.00495	CcSEcCtD
Midazolam—Fatigue—Furosemide—dilated cardiomyopathy	0.00328	0.00494	CcSEcCtD
Midazolam—Tremor—Lisinopril—dilated cardiomyopathy	0.00327	0.00494	CcSEcCtD
Midazolam—Pain—Furosemide—dilated cardiomyopathy	0.00325	0.0049	CcSEcCtD
Midazolam—Constipation—Furosemide—dilated cardiomyopathy	0.00325	0.0049	CcSEcCtD
Midazolam—Vertigo—Lisinopril—dilated cardiomyopathy	0.00314	0.00474	CcSEcCtD
Midazolam—Syncope—Lisinopril—dilated cardiomyopathy	0.00313	0.00473	CcSEcCtD
Midazolam—Feeling abnormal—Furosemide—dilated cardiomyopathy	0.00313	0.00473	CcSEcCtD
Midazolam—Cough—Lisinopril—dilated cardiomyopathy	0.00305	0.0046	CcSEcCtD
Midazolam—Urticaria—Furosemide—dilated cardiomyopathy	0.00302	0.00456	CcSEcCtD
Midazolam—Anxiety—Lisinopril—dilated cardiomyopathy	0.00296	0.00447	CcSEcCtD
Midazolam—Unspecified disorder of skin and subcutaneous tissue—Lisinopril—dilated cardiomyopathy	0.00295	0.00446	CcSEcCtD
Midazolam—Dry mouth—Lisinopril—dilated cardiomyopathy	0.00291	0.00439	CcSEcCtD
Midazolam—Confusional state—Lisinopril—dilated cardiomyopathy	0.00288	0.00434	CcSEcCtD
Midazolam—Anaphylactic shock—Lisinopril—dilated cardiomyopathy	0.00285	0.0043	CcSEcCtD
Midazolam—Shock—Lisinopril—dilated cardiomyopathy	0.00281	0.00423	CcSEcCtD
Midazolam—Hypersensitivity—Furosemide—dilated cardiomyopathy	0.0028	0.00423	CcSEcCtD
Midazolam—Tachycardia—Lisinopril—dilated cardiomyopathy	0.00278	0.0042	CcSEcCtD
Midazolam—Skin disorder—Lisinopril—dilated cardiomyopathy	0.00277	0.00418	CcSEcCtD
Midazolam—Asthenia—Furosemide—dilated cardiomyopathy	0.00273	0.00411	CcSEcCtD
Midazolam—Pruritus—Furosemide—dilated cardiomyopathy	0.00269	0.00406	CcSEcCtD
Midazolam—Hypotension—Lisinopril—dilated cardiomyopathy	0.00267	0.00402	CcSEcCtD
Midazolam—Paraesthesia—Lisinopril—dilated cardiomyopathy	0.00256	0.00386	CcSEcCtD
Midazolam—Dyspnoea—Lisinopril—dilated cardiomyopathy	0.00254	0.00384	CcSEcCtD
Midazolam—Somnolence—Lisinopril—dilated cardiomyopathy	0.00254	0.00383	CcSEcCtD
Midazolam—Dizziness—Furosemide—dilated cardiomyopathy	0.00251	0.00379	CcSEcCtD
Midazolam—Dyspepsia—Lisinopril—dilated cardiomyopathy	0.00251	0.00379	CcSEcCtD
Midazolam—Gastrointestinal disorder—Lisinopril—dilated cardiomyopathy	0.00246	0.00372	CcSEcCtD
Midazolam—Fatigue—Lisinopril—dilated cardiomyopathy	0.00246	0.00371	CcSEcCtD
Midazolam—Constipation—Lisinopril—dilated cardiomyopathy	0.00244	0.00368	CcSEcCtD
Midazolam—Pain—Lisinopril—dilated cardiomyopathy	0.00244	0.00368	CcSEcCtD
Midazolam—Vomiting—Furosemide—dilated cardiomyopathy	0.00242	0.00365	CcSEcCtD
Midazolam—Rash—Furosemide—dilated cardiomyopathy	0.0024	0.00362	CcSEcCtD
Midazolam—Dermatitis—Furosemide—dilated cardiomyopathy	0.00239	0.00361	CcSEcCtD
Midazolam—Headache—Furosemide—dilated cardiomyopathy	0.00238	0.00359	CcSEcCtD
Midazolam—Feeling abnormal—Lisinopril—dilated cardiomyopathy	0.00235	0.00355	CcSEcCtD
Midazolam—Urticaria—Lisinopril—dilated cardiomyopathy	0.00227	0.00342	CcSEcCtD
Midazolam—Nausea—Furosemide—dilated cardiomyopathy	0.00226	0.00341	CcSEcCtD
Midazolam—Hypersensitivity—Lisinopril—dilated cardiomyopathy	0.0021	0.00317	CcSEcCtD
Midazolam—Asthenia—Lisinopril—dilated cardiomyopathy	0.00205	0.00309	CcSEcCtD
Midazolam—Pruritus—Lisinopril—dilated cardiomyopathy	0.00202	0.00304	CcSEcCtD
Midazolam—Dizziness—Lisinopril—dilated cardiomyopathy	0.00189	0.00285	CcSEcCtD
Midazolam—Vomiting—Lisinopril—dilated cardiomyopathy	0.00181	0.00274	CcSEcCtD
Midazolam—Rash—Lisinopril—dilated cardiomyopathy	0.0018	0.00271	CcSEcCtD
Midazolam—Dermatitis—Lisinopril—dilated cardiomyopathy	0.0018	0.00271	CcSEcCtD
Midazolam—Headache—Lisinopril—dilated cardiomyopathy	0.00179	0.0027	CcSEcCtD
Midazolam—Nausea—Lisinopril—dilated cardiomyopathy	0.00169	0.00256	CcSEcCtD
Midazolam—GABRA1—Ion channel transport—PLN—dilated cardiomyopathy	0.00167	0.00541	CbGpPWpGaD
Midazolam—GABRB2—Transmission across Chemical Synapses—ACTN2—dilated cardiomyopathy	0.00157	0.00509	CbGpPWpGaD
Midazolam—GABRA5—Transmission across Chemical Synapses—ACTN2—dilated cardiomyopathy	0.00153	0.00495	CbGpPWpGaD
Midazolam—GABRA3—Transmission across Chemical Synapses—ACTN2—dilated cardiomyopathy	0.0015	0.00486	CbGpPWpGaD
Midazolam—GABRG3—Neuronal System—ABCC9—dilated cardiomyopathy	0.00149	0.00484	CbGpPWpGaD
Midazolam—GABRA2—Transmission across Chemical Synapses—ACTN2—dilated cardiomyopathy	0.00148	0.00477	CbGpPWpGaD
Midazolam—GABRB1—Neuronal System—ABCC9—dilated cardiomyopathy	0.00147	0.00476	CbGpPWpGaD
Midazolam—GABRB3—Transmission across Chemical Synapses—ACTN2—dilated cardiomyopathy	0.00147	0.00474	CbGpPWpGaD
Midazolam—GABRG2—Transmission across Chemical Synapses—ACTN2—dilated cardiomyopathy	0.00144	0.00466	CbGpPWpGaD
Midazolam—GABRG3—Neuronal System—ACTN2—dilated cardiomyopathy	0.00143	0.00464	CbGpPWpGaD
Midazolam—GABRB1—Neuronal System—ACTN2—dilated cardiomyopathy	0.00141	0.00457	CbGpPWpGaD
Midazolam—GABRA6—Neuronal System—ABCC9—dilated cardiomyopathy	0.00139	0.00451	CbGpPWpGaD
Midazolam—GABRA4—Neuronal System—ABCC9—dilated cardiomyopathy	0.00138	0.00445	CbGpPWpGaD
Midazolam—GABRA6—Neuronal System—ACTN2—dilated cardiomyopathy	0.00134	0.00432	CbGpPWpGaD
Midazolam—GABRA4—Neuronal System—ACTN2—dilated cardiomyopathy	0.00132	0.00427	CbGpPWpGaD
Midazolam—GABRA1—Transmission across Chemical Synapses—ACTN2—dilated cardiomyopathy	0.00126	0.00407	CbGpPWpGaD
Midazolam—GABRB2—Neuronal System—ABCC9—dilated cardiomyopathy	0.00126	0.00407	CbGpPWpGaD
Midazolam—GABRA5—Neuronal System—ABCC9—dilated cardiomyopathy	0.00122	0.00395	CbGpPWpGaD
Midazolam—UGT1A4—Aryl Hydrocarbon Receptor Pathway—EGFR—dilated cardiomyopathy	0.00121	0.00392	CbGpPWpGaD
Midazolam—GABRB2—Neuronal System—ACTN2—dilated cardiomyopathy	0.00121	0.0039	CbGpPWpGaD
Midazolam—GABRA3—Neuronal System—ABCC9—dilated cardiomyopathy	0.0012	0.00388	CbGpPWpGaD
Midazolam—CYP4B1—Metabolism—ANKRD1—dilated cardiomyopathy	0.0012	0.00387	CbGpPWpGaD
Midazolam—GABRA2—Neuronal System—ABCC9—dilated cardiomyopathy	0.00118	0.00382	CbGpPWpGaD
Midazolam—GABRB3—Neuronal System—ABCC9—dilated cardiomyopathy	0.00117	0.00379	CbGpPWpGaD
Midazolam—GABRA5—Neuronal System—ACTN2—dilated cardiomyopathy	0.00117	0.00379	CbGpPWpGaD
Midazolam—UGT1A4—Aryl Hydrocarbon Receptor Pathway—TNF—dilated cardiomyopathy	0.00115	0.00373	CbGpPWpGaD
Midazolam—GABRA3—Neuronal System—ACTN2—dilated cardiomyopathy	0.00115	0.00372	CbGpPWpGaD
Midazolam—GABRG2—Neuronal System—ABCC9—dilated cardiomyopathy	0.00115	0.00372	CbGpPWpGaD
Midazolam—GABRR1—Transmembrane transport of small molecules—RYR2—dilated cardiomyopathy	0.00113	0.00366	CbGpPWpGaD
Midazolam—GABRA2—Neuronal System—ACTN2—dilated cardiomyopathy	0.00113	0.00366	CbGpPWpGaD
Midazolam—CYP4B1—Metabolism—TAZ—dilated cardiomyopathy	0.00112	0.00364	CbGpPWpGaD
Midazolam—GABRB3—Neuronal System—ACTN2—dilated cardiomyopathy	0.00112	0.00363	CbGpPWpGaD
Midazolam—GABRG2—Neuronal System—ACTN2—dilated cardiomyopathy	0.0011	0.00357	CbGpPWpGaD
Midazolam—GABRR1—Transmembrane transport of small molecules—SLC22A5—dilated cardiomyopathy	0.0011	0.00356	CbGpPWpGaD
Midazolam—GABRR1—Transmembrane transport of small molecules—PLN—dilated cardiomyopathy	0.0011	0.00356	CbGpPWpGaD
Midazolam—GABRQ—Transmembrane transport of small molecules—RYR2—dilated cardiomyopathy	0.00108	0.00349	CbGpPWpGaD
Midazolam—GABRR2—Transmembrane transport of small molecules—RYR2—dilated cardiomyopathy	0.00108	0.00349	CbGpPWpGaD
Midazolam—SLC22A1—Transmission across Chemical Synapses—ACTN2—dilated cardiomyopathy	0.00108	0.00348	CbGpPWpGaD
Midazolam—GABRR2—Transmembrane transport of small molecules—SLC22A5—dilated cardiomyopathy	0.00105	0.0034	CbGpPWpGaD
Midazolam—GABRR2—Transmembrane transport of small molecules—PLN—dilated cardiomyopathy	0.00105	0.0034	CbGpPWpGaD
Midazolam—GABRQ—Transmembrane transport of small molecules—SLC22A5—dilated cardiomyopathy	0.00105	0.0034	CbGpPWpGaD
Midazolam—GABRQ—Transmembrane transport of small molecules—PLN—dilated cardiomyopathy	0.00105	0.0034	CbGpPWpGaD
Midazolam—CYP2E1—Vitamin A and Carotenoid Metabolism—CD36—dilated cardiomyopathy	0.00104	0.00338	CbGpPWpGaD
Midazolam—GABRR1—Transmembrane transport of small molecules—ABCC9—dilated cardiomyopathy	0.00102	0.00331	CbGpPWpGaD
Midazolam—CYP4B1—Metabolism—SDHA—dilated cardiomyopathy	0.00102	0.00329	CbGpPWpGaD
Midazolam—GABRA1—Neuronal System—ABCC9—dilated cardiomyopathy	0.00101	0.00325	CbGpPWpGaD
Midazolam—SLC22A1—SLC-mediated transmembrane transport—SLC22A5—dilated cardiomyopathy	0.000979	0.00317	CbGpPWpGaD
Midazolam—GABRR2—Transmembrane transport of small molecules—ABCC9—dilated cardiomyopathy	0.000976	0.00316	CbGpPWpGaD
Midazolam—GABRQ—Transmembrane transport of small molecules—ABCC9—dilated cardiomyopathy	0.000976	0.00316	CbGpPWpGaD
Midazolam—GABRA1—Neuronal System—ACTN2—dilated cardiomyopathy	0.000964	0.00312	CbGpPWpGaD
Midazolam—GABRG3—Transmembrane transport of small molecules—RYR2—dilated cardiomyopathy	0.000888	0.00287	CbGpPWpGaD
Midazolam—GABRB1—Transmembrane transport of small molecules—RYR2—dilated cardiomyopathy	0.000875	0.00283	CbGpPWpGaD
Midazolam—GABRG3—Transmembrane transport of small molecules—SLC22A5—dilated cardiomyopathy	0.000864	0.0028	CbGpPWpGaD
Midazolam—GABRG3—Transmembrane transport of small molecules—PLN—dilated cardiomyopathy	0.000864	0.0028	CbGpPWpGaD
Midazolam—SLC22A1—Neuronal System—ABCC9—dilated cardiomyopathy	0.00086	0.00278	CbGpPWpGaD
Midazolam—GABRB1—Transmembrane transport of small molecules—SLC22A5—dilated cardiomyopathy	0.000851	0.00275	CbGpPWpGaD
Midazolam—GABRB1—Transmembrane transport of small molecules—PLN—dilated cardiomyopathy	0.000851	0.00275	CbGpPWpGaD
Midazolam—GABRA6—Transmembrane transport of small molecules—RYR2—dilated cardiomyopathy	0.000828	0.00268	CbGpPWpGaD
Midazolam—SLC22A1—Neuronal System—ACTN2—dilated cardiomyopathy	0.000825	0.00267	CbGpPWpGaD
Midazolam—GABRA4—Transmembrane transport of small molecules—RYR2—dilated cardiomyopathy	0.000817	0.00265	CbGpPWpGaD
Midazolam—GABRA6—Transmembrane transport of small molecules—PLN—dilated cardiomyopathy	0.000805	0.00261	CbGpPWpGaD
Midazolam—GABRA6—Transmembrane transport of small molecules—SLC22A5—dilated cardiomyopathy	0.000805	0.00261	CbGpPWpGaD
Midazolam—GABRG3—Transmembrane transport of small molecules—ABCC9—dilated cardiomyopathy	0.000803	0.0026	CbGpPWpGaD
Midazolam—GABRA4—Transmembrane transport of small molecules—SLC22A5—dilated cardiomyopathy	0.000795	0.00257	CbGpPWpGaD
Midazolam—GABRA4—Transmembrane transport of small molecules—PLN—dilated cardiomyopathy	0.000795	0.00257	CbGpPWpGaD
Midazolam—GABRB1—Transmembrane transport of small molecules—ABCC9—dilated cardiomyopathy	0.000791	0.00256	CbGpPWpGaD
Midazolam—GABRA6—Transmembrane transport of small molecules—ABCC9—dilated cardiomyopathy	0.000749	0.00242	CbGpPWpGaD
Midazolam—UGT1A4—Metabolism—ANKRD1—dilated cardiomyopathy	0.000748	0.00242	CbGpPWpGaD
Midazolam—GABRB2—Transmembrane transport of small molecules—RYR2—dilated cardiomyopathy	0.000748	0.00242	CbGpPWpGaD
Midazolam—GABRA4—Transmembrane transport of small molecules—ABCC9—dilated cardiomyopathy	0.000739	0.00239	CbGpPWpGaD
Midazolam—ABCB1—Integrated Pancreatic Cancer Pathway—PLN—dilated cardiomyopathy	0.000735	0.00238	CbGpPWpGaD
Midazolam—GABRB2—Transmembrane transport of small molecules—PLN—dilated cardiomyopathy	0.000727	0.00235	CbGpPWpGaD
Midazolam—GABRB2—Transmembrane transport of small molecules—SLC22A5—dilated cardiomyopathy	0.000727	0.00235	CbGpPWpGaD
Midazolam—GABRA5—Transmembrane transport of small molecules—RYR2—dilated cardiomyopathy	0.000726	0.00235	CbGpPWpGaD
Midazolam—GABRB3—BDNF signaling pathway—RPS6KB1—dilated cardiomyopathy	0.000724	0.00234	CbGpPWpGaD
Midazolam—GABRR1—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—RAF1—dilated cardiomyopathy	0.00072	0.00233	CbGpPWpGaD
Midazolam—GABRA3—Transmembrane transport of small molecules—RYR2—dilated cardiomyopathy	0.000713	0.00231	CbGpPWpGaD
Midazolam—GABRA5—Transmembrane transport of small molecules—SLC22A5—dilated cardiomyopathy	0.000707	0.00229	CbGpPWpGaD
Midazolam—GABRA5—Transmembrane transport of small molecules—PLN—dilated cardiomyopathy	0.000707	0.00229	CbGpPWpGaD
Midazolam—UGT1A4—Metabolism—TAZ—dilated cardiomyopathy	0.000703	0.00228	CbGpPWpGaD
Midazolam—GABRA2—Transmembrane transport of small molecules—RYR2—dilated cardiomyopathy	0.000701	0.00227	CbGpPWpGaD
Midazolam—GABRB3—Transmembrane transport of small molecules—RYR2—dilated cardiomyopathy	0.000696	0.00225	CbGpPWpGaD
Midazolam—GABRA3—Transmembrane transport of small molecules—PLN—dilated cardiomyopathy	0.000694	0.00225	CbGpPWpGaD
Midazolam—GABRA3—Transmembrane transport of small molecules—SLC22A5—dilated cardiomyopathy	0.000694	0.00225	CbGpPWpGaD
Midazolam—GABRA1—SIDS Susceptibility Pathways—GJA1—dilated cardiomyopathy	0.000691	0.00224	CbGpPWpGaD
Midazolam—GABRR2—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—RAF1—dilated cardiomyopathy	0.000687	0.00222	CbGpPWpGaD
Midazolam—GABRQ—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—RAF1—dilated cardiomyopathy	0.000687	0.00222	CbGpPWpGaD
Midazolam—GABRG2—Transmembrane transport of small molecules—RYR2—dilated cardiomyopathy	0.000684	0.00221	CbGpPWpGaD
Midazolam—GABRA2—Transmembrane transport of small molecules—SLC22A5—dilated cardiomyopathy	0.000682	0.00221	CbGpPWpGaD
Midazolam—GABRA2—Transmembrane transport of small molecules—PLN—dilated cardiomyopathy	0.000682	0.00221	CbGpPWpGaD
Midazolam—GABRB3—Transmembrane transport of small molecules—SLC22A5—dilated cardiomyopathy	0.000677	0.00219	CbGpPWpGaD
Midazolam—GABRB3—Transmembrane transport of small molecules—PLN—dilated cardiomyopathy	0.000677	0.00219	CbGpPWpGaD
Midazolam—GABRB2—Transmembrane transport of small molecules—ABCC9—dilated cardiomyopathy	0.000676	0.00219	CbGpPWpGaD
Midazolam—GABRG2—Transmembrane transport of small molecules—PLN—dilated cardiomyopathy	0.000665	0.00215	CbGpPWpGaD
Midazolam—GABRG2—Transmembrane transport of small molecules—SLC22A5—dilated cardiomyopathy	0.000665	0.00215	CbGpPWpGaD
Midazolam—GABRA5—Transmembrane transport of small molecules—ABCC9—dilated cardiomyopathy	0.000657	0.00213	CbGpPWpGaD
Midazolam—GABRB3—BDNF signaling pathway—RAC1—dilated cardiomyopathy	0.000654	0.00212	CbGpPWpGaD
Midazolam—GABRA3—Transmembrane transport of small molecules—ABCC9—dilated cardiomyopathy	0.000645	0.00209	CbGpPWpGaD
Midazolam—GABRR1—Ion channel transport—RAF1—dilated cardiomyopathy	0.000641	0.00207	CbGpPWpGaD
Midazolam—UGT1A4—Metabolism—SDHA—dilated cardiomyopathy	0.000636	0.00206	CbGpPWpGaD
Midazolam—GABRA2—Transmembrane transport of small molecules—ABCC9—dilated cardiomyopathy	0.000634	0.00205	CbGpPWpGaD
Midazolam—GABRB3—Transmembrane transport of small molecules—ABCC9—dilated cardiomyopathy	0.00063	0.00204	CbGpPWpGaD
Midazolam—CYP4B1—Metabolism of lipids and lipoproteins—GPX1—dilated cardiomyopathy	0.00062	0.00201	CbGpPWpGaD
Midazolam—GABRG2—Transmembrane transport of small molecules—ABCC9—dilated cardiomyopathy	0.000618	0.002	CbGpPWpGaD
Midazolam—ABCB1—Allograft Rejection—AGTR1—dilated cardiomyopathy	0.000618	0.002	CbGpPWpGaD
Midazolam—GABRR2—Ion channel transport—RAF1—dilated cardiomyopathy	0.000611	0.00198	CbGpPWpGaD
Midazolam—GABRQ—Ion channel transport—RAF1—dilated cardiomyopathy	0.000611	0.00198	CbGpPWpGaD
Midazolam—CYP4B1—Metabolism of lipids and lipoproteins—CD36—dilated cardiomyopathy	0.000604	0.00195	CbGpPWpGaD
Midazolam—GABRA1—SIDS Susceptibility Pathways—IL10—dilated cardiomyopathy	0.000599	0.00194	CbGpPWpGaD
Midazolam—GABRA1—Transmembrane transport of small molecules—RYR2—dilated cardiomyopathy	0.000598	0.00193	CbGpPWpGaD
Midazolam—GABRA1—Transmembrane transport of small molecules—SLC22A5—dilated cardiomyopathy	0.000581	0.00188	CbGpPWpGaD
Midazolam—GABRA1—Transmembrane transport of small molecules—PLN—dilated cardiomyopathy	0.000581	0.00188	CbGpPWpGaD
Midazolam—GABRG3—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—RAF1—dilated cardiomyopathy	0.000566	0.00183	CbGpPWpGaD
Midazolam—GABRB1—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—RAF1—dilated cardiomyopathy	0.000557	0.0018	CbGpPWpGaD
Midazolam—CYP4B1—Metabolism of lipids and lipoproteins—AGT—dilated cardiomyopathy	0.000544	0.00176	CbGpPWpGaD
Midazolam—GABRR1—Transmission across Chemical Synapses—RAF1—dilated cardiomyopathy	0.000541	0.00175	CbGpPWpGaD
Midazolam—GABRA1—Transmembrane transport of small molecules—ABCC9—dilated cardiomyopathy	0.000541	0.00175	CbGpPWpGaD
Midazolam—GABRA6—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—RAF1—dilated cardiomyopathy	0.000527	0.00171	CbGpPWpGaD
Midazolam—GABRA4—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—RAF1—dilated cardiomyopathy	0.000521	0.00169	CbGpPWpGaD
Midazolam—ABCB1—Allograft Rejection—IL10—dilated cardiomyopathy	0.000518	0.00168	CbGpPWpGaD
Midazolam—GABRR2—Transmission across Chemical Synapses—RAF1—dilated cardiomyopathy	0.000517	0.00167	CbGpPWpGaD
Midazolam—GABRQ—Transmission across Chemical Synapses—RAF1—dilated cardiomyopathy	0.000517	0.00167	CbGpPWpGaD
Midazolam—SLC22A1—Transmembrane transport of small molecules—RYR2—dilated cardiomyopathy	0.000511	0.00166	CbGpPWpGaD
Midazolam—GABRG3—Ion channel transport—RAF1—dilated cardiomyopathy	0.000503	0.00163	CbGpPWpGaD
Midazolam—SLC22A1—Transmembrane transport of small molecules—SLC22A5—dilated cardiomyopathy	0.000498	0.00161	CbGpPWpGaD
Midazolam—SLC22A1—Transmembrane transport of small molecules—PLN—dilated cardiomyopathy	0.000498	0.00161	CbGpPWpGaD
Midazolam—GABRB1—Ion channel transport—RAF1—dilated cardiomyopathy	0.000496	0.00161	CbGpPWpGaD
Midazolam—ABCB1—Allograft Rejection—FASLG—dilated cardiomyopathy	0.000482	0.00156	CbGpPWpGaD
Midazolam—GABRB2—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—RAF1—dilated cardiomyopathy	0.000476	0.00154	CbGpPWpGaD
Midazolam—GABRA6—Ion channel transport—RAF1—dilated cardiomyopathy	0.000469	0.00152	CbGpPWpGaD
Midazolam—ABCB1—Allograft Rejection—FAS—dilated cardiomyopathy	0.000464	0.0015	CbGpPWpGaD
Midazolam—GABRA4—Ion channel transport—RAF1—dilated cardiomyopathy	0.000463	0.0015	CbGpPWpGaD
Midazolam—GABRA5—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—RAF1—dilated cardiomyopathy	0.000463	0.0015	CbGpPWpGaD
Midazolam—SLC22A1—Transmembrane transport of small molecules—ABCC9—dilated cardiomyopathy	0.000463	0.0015	CbGpPWpGaD
Midazolam—GABRA3—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—RAF1—dilated cardiomyopathy	0.000454	0.00147	CbGpPWpGaD
Midazolam—GABRA2—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—RAF1—dilated cardiomyopathy	0.000447	0.00145	CbGpPWpGaD
Midazolam—GABRB3—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—RAF1—dilated cardiomyopathy	0.000444	0.00144	CbGpPWpGaD
Midazolam—GABRG2—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—RAF1—dilated cardiomyopathy	0.000436	0.00141	CbGpPWpGaD
Midazolam—GABRB3—BDNF signaling pathway—RAF1—dilated cardiomyopathy	0.000434	0.0014	CbGpPWpGaD
Midazolam—GABRG3—Transmission across Chemical Synapses—RAF1—dilated cardiomyopathy	0.000425	0.00138	CbGpPWpGaD
Midazolam—GABRB2—Ion channel transport—RAF1—dilated cardiomyopathy	0.000424	0.00137	CbGpPWpGaD
Midazolam—GABRB1—Transmission across Chemical Synapses—RAF1—dilated cardiomyopathy	0.000419	0.00136	CbGpPWpGaD
Midazolam—GABRR1—Neuronal System—RAF1—dilated cardiomyopathy	0.000415	0.00134	CbGpPWpGaD
Midazolam—GABRA5—Ion channel transport—RAF1—dilated cardiomyopathy	0.000412	0.00133	CbGpPWpGaD
Midazolam—GABRA3—Ion channel transport—RAF1—dilated cardiomyopathy	0.000404	0.00131	CbGpPWpGaD
Midazolam—GABRA2—Ion channel transport—RAF1—dilated cardiomyopathy	0.000397	0.00129	CbGpPWpGaD
Midazolam—GABRA6—Transmission across Chemical Synapses—RAF1—dilated cardiomyopathy	0.000396	0.00128	CbGpPWpGaD
Midazolam—GABRQ—Neuronal System—RAF1—dilated cardiomyopathy	0.000396	0.00128	CbGpPWpGaD
Midazolam—GABRR2—Neuronal System—RAF1—dilated cardiomyopathy	0.000396	0.00128	CbGpPWpGaD
Midazolam—GABRB3—Ion channel transport—RAF1—dilated cardiomyopathy	0.000395	0.00128	CbGpPWpGaD
Midazolam—GABRA4—Transmission across Chemical Synapses—RAF1—dilated cardiomyopathy	0.000391	0.00127	CbGpPWpGaD
Midazolam—GABRG2—Ion channel transport—RAF1—dilated cardiomyopathy	0.000388	0.00125	CbGpPWpGaD
Midazolam—GABRA1—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—RAF1—dilated cardiomyopathy	0.000381	0.00123	CbGpPWpGaD
Midazolam—CYP3A7—Metabolism—ANKRD1—dilated cardiomyopathy	0.000361	0.00117	CbGpPWpGaD
Midazolam—GABRB2—Transmission across Chemical Synapses—RAF1—dilated cardiomyopathy	0.000358	0.00116	CbGpPWpGaD
Midazolam—GABRA5—Transmission across Chemical Synapses—RAF1—dilated cardiomyopathy	0.000348	0.00113	CbGpPWpGaD
Midazolam—GABRA3—Transmission across Chemical Synapses—RAF1—dilated cardiomyopathy	0.000342	0.00111	CbGpPWpGaD
Midazolam—CYP3A7—Metabolism—TAZ—dilated cardiomyopathy	0.00034	0.0011	CbGpPWpGaD
Midazolam—GABRA1—Ion channel transport—RAF1—dilated cardiomyopathy	0.000339	0.0011	CbGpPWpGaD
Midazolam—SLC22A1—Metabolism—ANKRD1—dilated cardiomyopathy	0.000336	0.00109	CbGpPWpGaD
Midazolam—GABRA2—Transmission across Chemical Synapses—RAF1—dilated cardiomyopathy	0.000336	0.00109	CbGpPWpGaD
Midazolam—GABRB3—Transmission across Chemical Synapses—RAF1—dilated cardiomyopathy	0.000333	0.00108	CbGpPWpGaD
Midazolam—GABRG2—Transmission across Chemical Synapses—RAF1—dilated cardiomyopathy	0.000327	0.00106	CbGpPWpGaD
Midazolam—GABRG3—Neuronal System—RAF1—dilated cardiomyopathy	0.000326	0.00105	CbGpPWpGaD
Midazolam—GABRB1—Neuronal System—RAF1—dilated cardiomyopathy	0.000321	0.00104	CbGpPWpGaD
Midazolam—SLC22A1—Metabolism—TAZ—dilated cardiomyopathy	0.000316	0.00102	CbGpPWpGaD
Midazolam—CYP3A7—Metabolism—SDHA—dilated cardiomyopathy	0.000307	0.000994	CbGpPWpGaD
Midazolam—GABRA6—Neuronal System—RAF1—dilated cardiomyopathy	0.000304	0.000983	CbGpPWpGaD
Midazolam—GABRA4—Neuronal System—RAF1—dilated cardiomyopathy	0.0003	0.000971	CbGpPWpGaD
Midazolam—ABCB1—Transmembrane transport of small molecules—RYR2—dilated cardiomyopathy	0.0003	0.00097	CbGpPWpGaD
Midazolam—ABCB1—Transmembrane transport of small molecules—SLC22A5—dilated cardiomyopathy	0.000292	0.000944	CbGpPWpGaD
Midazolam—ABCB1—Transmembrane transport of small molecules—PLN—dilated cardiomyopathy	0.000292	0.000944	CbGpPWpGaD
Midazolam—GABRA1—Transmission across Chemical Synapses—RAF1—dilated cardiomyopathy	0.000286	0.000926	CbGpPWpGaD
Midazolam—SLC22A1—Metabolism—SDHA—dilated cardiomyopathy	0.000286	0.000925	CbGpPWpGaD
Midazolam—CYP4B1—Metabolism—GPX1—dilated cardiomyopathy	0.000276	0.000894	CbGpPWpGaD
Midazolam—GABRB2—Neuronal System—RAF1—dilated cardiomyopathy	0.000274	0.000888	CbGpPWpGaD
Midazolam—ABCB1—Transmembrane transport of small molecules—ABCC9—dilated cardiomyopathy	0.000271	0.000877	CbGpPWpGaD
Midazolam—CYP4B1—Metabolism—CD36—dilated cardiomyopathy	0.000269	0.00087	CbGpPWpGaD
Midazolam—CYP2B6—Metabolism—ANKRD1—dilated cardiomyopathy	0.000267	0.000865	CbGpPWpGaD
Midazolam—GABRA5—Neuronal System—RAF1—dilated cardiomyopathy	0.000267	0.000863	CbGpPWpGaD
Midazolam—GABRA3—Neuronal System—RAF1—dilated cardiomyopathy	0.000262	0.000847	CbGpPWpGaD
Midazolam—CYP2E1—Metabolism—ANKRD1—dilated cardiomyopathy	0.000262	0.000847	CbGpPWpGaD
Midazolam—CYP3A5—Metabolism—ANKRD1—dilated cardiomyopathy	0.000261	0.000845	CbGpPWpGaD
Midazolam—GABRA2—Neuronal System—RAF1—dilated cardiomyopathy	0.000257	0.000832	CbGpPWpGaD
Midazolam—GABRB3—Neuronal System—RAF1—dilated cardiomyopathy	0.000256	0.000827	CbGpPWpGaD
Midazolam—CYP2B6—Metabolism—TAZ—dilated cardiomyopathy	0.000251	0.000813	CbGpPWpGaD
Midazolam—GABRG2—Neuronal System—RAF1—dilated cardiomyopathy	0.000251	0.000812	CbGpPWpGaD
Midazolam—CYP2E1—Metabolism—TAZ—dilated cardiomyopathy	0.000246	0.000796	CbGpPWpGaD
Midazolam—CYP3A5—Metabolism—TAZ—dilated cardiomyopathy	0.000246	0.000795	CbGpPWpGaD
Midazolam—SLC22A1—Transmission across Chemical Synapses—RAF1—dilated cardiomyopathy	0.000245	0.000793	CbGpPWpGaD
Midazolam—CYP4B1—Metabolism—AGT—dilated cardiomyopathy	0.000242	0.000784	CbGpPWpGaD
Midazolam—ABCB1—Integrated Pancreatic Cancer Pathway—FASLG—dilated cardiomyopathy	0.000238	0.000769	CbGpPWpGaD
Midazolam—ABCB1—Integrated Pancreatic Cancer Pathway—FAS—dilated cardiomyopathy	0.000229	0.000742	CbGpPWpGaD
Midazolam—GABRA1—SIDS Susceptibility Pathways—TNF—dilated cardiomyopathy	0.000228	0.000738	CbGpPWpGaD
Midazolam—CYP2B6—Metabolism—SDHA—dilated cardiomyopathy	0.000227	0.000735	CbGpPWpGaD
Midazolam—ABCB1—Integrated Pancreatic Cancer Pathway—RAC1—dilated cardiomyopathy	0.000225	0.000727	CbGpPWpGaD
Midazolam—GABRR1—Transmembrane transport of small molecules—RAF1—dilated cardiomyopathy	0.000223	0.000722	CbGpPWpGaD
Midazolam—CYP2E1—Metabolism—SDHA—dilated cardiomyopathy	0.000223	0.00072	CbGpPWpGaD
Midazolam—CYP3A5—Metabolism—SDHA—dilated cardiomyopathy	0.000222	0.000719	CbGpPWpGaD
Midazolam—GABRA1—Neuronal System—RAF1—dilated cardiomyopathy	0.000219	0.00071	CbGpPWpGaD
Midazolam—GABRQ—Transmembrane transport of small molecules—RAF1—dilated cardiomyopathy	0.000213	0.000689	CbGpPWpGaD
Midazolam—GABRR2—Transmembrane transport of small molecules—RAF1—dilated cardiomyopathy	0.000213	0.000689	CbGpPWpGaD
Midazolam—ABCB1—Allograft Rejection—TNF—dilated cardiomyopathy	0.000197	0.000638	CbGpPWpGaD
Midazolam—ABCB1—Metabolism—ANKRD1—dilated cardiomyopathy	0.000197	0.000638	CbGpPWpGaD
Midazolam—SLC22A1—Neuronal System—RAF1—dilated cardiomyopathy	0.000188	0.000607	CbGpPWpGaD
Midazolam—ABCB1—Metabolism—TAZ—dilated cardiomyopathy	0.000185	0.0006	CbGpPWpGaD
Midazolam—GABRG3—Transmembrane transport of small molecules—RAF1—dilated cardiomyopathy	0.000175	0.000567	CbGpPWpGaD
Midazolam—UGT1A4—Metabolism—GPX1—dilated cardiomyopathy	0.000173	0.000559	CbGpPWpGaD
Midazolam—GABRB1—Transmembrane transport of small molecules—RAF1—dilated cardiomyopathy	0.000173	0.000559	CbGpPWpGaD
Midazolam—UGT1A4—Metabolism—CD36—dilated cardiomyopathy	0.000168	0.000545	CbGpPWpGaD
Midazolam—ABCB1—Metabolism—SDHA—dilated cardiomyopathy	0.000168	0.000542	CbGpPWpGaD
Midazolam—GABRA6—Transmembrane transport of small molecules—RAF1—dilated cardiomyopathy	0.000163	0.000529	CbGpPWpGaD
Midazolam—GABRA4—Transmembrane transport of small molecules—RAF1—dilated cardiomyopathy	0.000161	0.000522	CbGpPWpGaD
Midazolam—UGT1A4—Metabolism—AGT—dilated cardiomyopathy	0.000151	0.00049	CbGpPWpGaD
Midazolam—ABCB1—Integrated Pancreatic Cancer Pathway—RAF1—dilated cardiomyopathy	0.000149	0.000482	CbGpPWpGaD
Midazolam—GABRB2—Transmembrane transport of small molecules—RAF1—dilated cardiomyopathy	0.000147	0.000477	CbGpPWpGaD
Midazolam—GABRA5—Transmembrane transport of small molecules—RAF1—dilated cardiomyopathy	0.000143	0.000464	CbGpPWpGaD
Midazolam—GABRA3—Transmembrane transport of small molecules—RAF1—dilated cardiomyopathy	0.000141	0.000455	CbGpPWpGaD
Midazolam—GABRA2—Transmembrane transport of small molecules—RAF1—dilated cardiomyopathy	0.000138	0.000448	CbGpPWpGaD
Midazolam—GABRB3—Transmembrane transport of small molecules—RAF1—dilated cardiomyopathy	0.000137	0.000445	CbGpPWpGaD
Midazolam—GABRG2—Transmembrane transport of small molecules—RAF1—dilated cardiomyopathy	0.000135	0.000437	CbGpPWpGaD
Midazolam—CYP3A4—Metabolism—ANKRD1—dilated cardiomyopathy	0.000121	0.000393	CbGpPWpGaD
Midazolam—GABRA1—Transmembrane transport of small molecules—RAF1—dilated cardiomyopathy	0.000118	0.000382	CbGpPWpGaD
Midazolam—CYP3A4—Metabolism—TAZ—dilated cardiomyopathy	0.000114	0.000369	CbGpPWpGaD
Midazolam—CYP3A4—Metabolism—SDHA—dilated cardiomyopathy	0.000103	0.000334	CbGpPWpGaD
Midazolam—ABCB1—Integrated Pancreatic Cancer Pathway—EGFR—dilated cardiomyopathy	0.000102	0.000331	CbGpPWpGaD
Midazolam—SLC22A1—Transmembrane transport of small molecules—RAF1—dilated cardiomyopathy	0.000101	0.000327	CbGpPWpGaD
Midazolam—ABCB1—Integrated Pancreatic Cancer Pathway—TNF—dilated cardiomyopathy	9.73e-05	0.000315	CbGpPWpGaD
Midazolam—CYP3A7—Metabolism—GPX1—dilated cardiomyopathy	8.34e-05	0.00027	CbGpPWpGaD
Midazolam—CYP3A7—Metabolism—CD36—dilated cardiomyopathy	8.13e-05	0.000263	CbGpPWpGaD
Midazolam—SLC22A1—Metabolism—GPX1—dilated cardiomyopathy	7.77e-05	0.000251	CbGpPWpGaD
Midazolam—SLC22A1—Metabolism—CD36—dilated cardiomyopathy	7.56e-05	0.000245	CbGpPWpGaD
Midazolam—CYP3A7—Metabolism—AGT—dilated cardiomyopathy	7.32e-05	0.000237	CbGpPWpGaD
Midazolam—SLC22A1—Metabolism—AGT—dilated cardiomyopathy	6.81e-05	0.00022	CbGpPWpGaD
Midazolam—CYP2B6—Metabolism—GPX1—dilated cardiomyopathy	6.17e-05	0.0002	CbGpPWpGaD
Midazolam—CYP2E1—Metabolism—GPX1—dilated cardiomyopathy	6.04e-05	0.000196	CbGpPWpGaD
Midazolam—CYP3A5—Metabolism—GPX1—dilated cardiomyopathy	6.03e-05	0.000195	CbGpPWpGaD
Midazolam—CYP2B6—Metabolism—CD36—dilated cardiomyopathy	6.01e-05	0.000195	CbGpPWpGaD
Midazolam—ABCB1—Transmembrane transport of small molecules—RAF1—dilated cardiomyopathy	5.91e-05	0.000191	CbGpPWpGaD
Midazolam—CYP2E1—Metabolism—CD36—dilated cardiomyopathy	5.89e-05	0.000191	CbGpPWpGaD
Midazolam—CYP3A5—Metabolism—CD36—dilated cardiomyopathy	5.87e-05	0.00019	CbGpPWpGaD
Midazolam—CYP2B6—Metabolism—AGT—dilated cardiomyopathy	5.41e-05	0.000175	CbGpPWpGaD
Midazolam—CYP2E1—Metabolism—AGT—dilated cardiomyopathy	5.3e-05	0.000172	CbGpPWpGaD
Midazolam—CYP3A5—Metabolism—AGT—dilated cardiomyopathy	5.29e-05	0.000171	CbGpPWpGaD
Midazolam—ABCB1—Metabolism—GPX1—dilated cardiomyopathy	4.55e-05	0.000147	CbGpPWpGaD
Midazolam—ABCB1—Metabolism—CD36—dilated cardiomyopathy	4.43e-05	0.000143	CbGpPWpGaD
Midazolam—ABCB1—Metabolism—AGT—dilated cardiomyopathy	3.99e-05	0.000129	CbGpPWpGaD
Midazolam—CYP3A4—Metabolism—GPX1—dilated cardiomyopathy	2.8e-05	9.08e-05	CbGpPWpGaD
Midazolam—CYP3A4—Metabolism—CD36—dilated cardiomyopathy	2.73e-05	8.84e-05	CbGpPWpGaD
Midazolam—CYP3A4—Metabolism—AGT—dilated cardiomyopathy	2.46e-05	7.96e-05	CbGpPWpGaD
